These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1216 related articles for article (PubMed ID: 34744510)

  • 1. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Score Combining Magnetic Resonance Spectroscopy Parameters and Systemic Immune-Inflammation Index Improves Prognosis Prediction in Non-Small Cell Lung Cancer Patients With Brain Metastases After Stereotactic Radiotherapy.
    Guo D; Liu J; Li Y; Chen Q; Zhao Y; Guo X; Zhu S; Ji S
    Front Oncol; 2022; 12():762230. PubMed ID: 35756607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapy.
    Wang Q; Tan X; Deng G; Fu S; Li J; Li Z
    BMC Pulm Med; 2022 Mar; 22(1):75. PubMed ID: 35241046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs.
    Deng C; Zhang N; Wang Y; Jiang S; Lu M; Huang Y; Ma J; Hu C; Hou T
    Medicine (Baltimore); 2019 Aug; 98(33):e16875. PubMed ID: 31415428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy.
    Chen D; Qin H; Deng G; Wang Q; Wang H; Liu X
    Clin Transl Oncol; 2023 Jan; 25(1):226-235. PubMed ID: 36070068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.
    Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis.
    Xu S; Cao S; Yu Y
    J Cancer Res Ther; 2021 Dec; 17(7):1636-1642. PubMed ID: 35381733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
    Shi X; Li H; Xu Y; Nyalali AMK; Li F
    Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Huang T; Zhang H; Zhao Y; Li Y; Wang G; Zhang Y; Guo D; Ji S; Sun Z
    Future Oncol; 2021 Jun; 17(17):2141-2149. PubMed ID: 33635094
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy.
    Chen J; Huang W; Xu X; Fan S; Zhang Q; Li X; Zeng Z; He J
    Front Oncol; 2023; 13():1076428. PubMed ID: 37251953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
    Matsubara S; Mabuchi S; Takeda Y; Kawahara N; Kobayashi H
    PLoS One; 2021; 16(5):e0248871. PubMed ID: 33989285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index on short- and long-term outcome following surgery for spinal metastases.
    Ryvlin J; Kim SW; Hamad MK; Fourman MS; Eleswarapu A; Murthy SG; Gelfand Y; De la Garza Ramos R; Yassari R
    J Neurosurg Spine; 2024 Apr; 40(4):475-484. PubMed ID: 38157531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
    Zhang Y; Kong FF; Zhu ZQ; Shan HX
    BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
    Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
    Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
    Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
    Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy.
    Fan R; Chen Y; Xu G; Pan W; Lv Y; Zhang Z
    Front Oncol; 2023; 13():996312. PubMed ID: 37077828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.